Skip to content

Guided by light: Optimizing surgical excision of oral cancer using real-time fluorescence imaging

Guided by light: Optimizing surgical excision of oral cancer using real-time fluorescence imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24301
Enrollment
29
Registered
2019-09-27
Start date
2020-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Squamous Cell Carcinoma of the Oral Cavity

Interventions

Sponsors

Erasmus University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with biopsy-proven squamous cell carcinoma of the oral cavity, eligible for surgical resection of the primary tumor; 2) = 18 years of age; 3) Before patient registration, written informed consent must be given according to ICH/GCP, and national/local regulations. 4) Screening ECG and clinical laboratory test results are within normal limits, or if any are outside of normal limits, they are considered to be clinically insignificant; 5) The patient has a normal or clinically acceptable medical history, physical examination, and vital signs findings at screening; 6) Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial.

Exclusion criteria

Exclusion criteria: 1) Previous surgery, chemotherapy or radiotherapy to the oral cavity; 2) History of a clinically significant allergy or anaphylactic reactions to any of the components of the agent. 3) Patients pregnant or breastfeeding, lack of effective contraception in male or female patients with reproductive potential; 4) Any condition that the investigator considers to be potentially jeopardizing the patients well-being or the study objectives.

Design outcomes

Primary

MeasureTime frame
1. Mean tumor-to-background ratio (TBR) 2. Rate of adequate (i.e. >5mm clear) tumor resection margins

Secondary

MeasureTime frame
1. Sensitivity, specificity, positive and negative predictive values 2. Co-localization of FLI with immunohistochemistry on pathology slides 3. Percentage of extra tissue resection based on FLI-driven frozen sections 4. Operation time 5. FLI of lymph node metastases after neck dissection

Contacts

Public ContactStijn Keereweer

Erasmus University Medical Center

s.keereweer@erasmusmc.nl010 7041357

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)